, APAC
/Freepik

Lockton bags 4th year of double-digit growth in organic revenues

It climbed 14% YoY.

Independent insurance brokerage, Lockton, pencilled a revenue of $3.55b for its fiscal year ended 30 April 2024, a 14.9% year-on-year (YoY) climb.

Thanks to continued strength across all business segments and geographies. Lockton was able to achieve a recurring 96% client retention rate.

Further, its consolidated global revenue saw $3.55b, a 15% YoY increase. This was attributable to the 14% organic revenue growth. FY 2024 marks the fourth year in a row the firm recorded a double-digit organic global revenue growth and a five-year organic revenue CAGR of 15%.

Its international operations bagged $926m in revenue for the year, which was a 24% YoY surge, surpassing the five-year organic revenue CAGR of 16%.

“Looking forward into fiscal 2025 and beyond, Lockton remains well positioned to deliver upon its legacy of strong organic revenue growth. Importantly, Lockton maintains a conservative, all-weather capital structure that will allow us to continue to invest in our people and our clients. We will continue to invest in industry-leading talent and continue to develop our suite of capabilities and expertise we offer our clients,” Ron Lockton, Chairman and CEO said in a media release.

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.